Using voice reminders and free reading glasses to boost diabetes eye care in Dinajpur, Bangladesh
Official title: Improving Patient-centered Care for Diabetes in Bangladesh Through "Dynamic Integration" of Vision Care on the Demand Side
Run by Orbis · NCT06968611 · Data updated 2026-11-12
This project will test whether automated voice-message reminders that talk about vision-loss risk, combined with free reading glasses, help people with diabetes in Dinajpur, Bangladesh keep their diabetes and eye appointments and get better patient-centered care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 30 Years and up |
| Sex | All |
| Enrollment | 640 (estimated) |
| Sponsor | Orbis Academic / other |
| Locations | 2 sites (Dinajpur and 1 other locations) |
| Status | Recruiting |
| Started | August 25, 2025 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | October 22, 2026 |
| Trial ID | NCT06968611 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 30 diagnosed with diabetes within the past six months, currently treated at Dinajpur Diabetes Hospital, who have a mobile phone and can give informed consent are ideal candidates.
✕Probably not a fit
People whose vision loss is due to other major eye diseases or who have severe medical conditions that prevent follow-up (for example stroke or advanced dementia) are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants receiving care at Dinajpur diabetes services will be sent automated voice messages and offered free reading glasses as part of an intervention to encourage diabetes and diabetic retinopathy (DR) service uptake. The primary comparison is between messages that include information about vision-loss risk plus appointment reminders and messages that only give appointment reminders. The main outcome is the proportion of patients completing scheduled DM and DR appointments within three weeks of the scheduled date, with a cost-effectiveness analysis of intervention cost per additional compliant patient. Enrollment is limited to adults over 30 recently diagnosed with diabetes who are treated at Dinajpur Diabetes Hospital and can receive voice calls.
Why it matters
Potential benefit: If successful, the approach could increase appointment attendance and earlier detection of diabetic eye disease, potentially reducing avoidable sight loss.
How similar studies have gone: Reminder-based messaging has improved clinic attendance in many settings, though combining vision-risk messaging with free glasses in this specific population is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with DM within the last 6 months * Over 30 years of age * Currently treated at the Dinajpur Diabetes Hospital * Possess a mobile phone to receive voice messages * Willingness to participate in the study, and ability to give informed consent Exclusion Criteria: * Other significant causes of vision loss * Medical conditions that could impair compliance with follow-up (such as stroke, dementia, etc.)
Where it's running
-
Gausul Azam BNSB Eye Hospital
Dinajpur, Bangladesh Recruiting -
Dinajpur Diabetes & Swasthoseba Hospital
Dinajpur Sadar, Bangladesh Recruiting
Study contacts
- Principal investigator: Munir Ahmed — Orbis Bangladesh
- Study coordinator: Lutful Husain
- Email: lutful.husain@orbis.org
- Phone: +88 01711626852
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using eye exam results to guide diabetes care for people with diabetic retinopathy in Dinajpur
This project will try sending specific diabetes management recommendations based on patients' eye exams to diabetes doctors to see if people with diabetes and diabetic retinopathy reach WHO blood sugar targets more often.
-
Preventing lower limb artery disease in adults with diabetes using a risk-prediction model and HAPA-based nursing
A risk-prediction model is tested in adults with type 2 diabetes to see if a nursing plan based on the HAPA model can reduce peripheral artery disease in the legs.
-
Automated AI system to detect diabetic retinopathy in adults with diabetes
A AI-based software device is being tested to automatically detect diabetic retinopathy from retinal images in adults with diabetes.
-
DiaFootCare: a mobile app to help adults with diabetic foot ulcers manage self-care in Oman
A mobile app called DiaFootCare will be tested to see if it helps adults with diabetic foot ulcers in Oman take better care of themselves and improve healing compared with usual care.
-
Predictive CGM with App for people with type 1 or insulin-treated type 2 diabetes
This study tests whether using the Accu-Chek SmartGuide CGM with its Predict App can reduce fear of hypoglycemia and improve related behaviors and confidence in adults with type 1 or insulin-treated type 2 diabetes.
-
SugarVita 2.0: a 12-week digital game for adults with type 2 diabetes
This 12-week pilot tests SugarVita 2.0, a serious digital game, to see if it helps adults with type 2 diabetes manage their condition and feel more confident.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.